What’s new at SeqOne?
New platform features, customer success stories, awards and other great news about SeqOne…. you’ll find it all here. Journalists, we have a dedicated page for you.
-
News Platform features Press release Science9 February 2023
SeqOne Genomics and the French Thrombotic MicroAngiopathies National reference center (CNR-MAT) pioneer the use of Oxford Nanopore sequencing technology to improve patient outcomes in kidney disease while reducing turnaround times
Montpellier, February 9th, 2023: SeqOne today announced the results of a long-standing research collaboration with Pr. Laurent Mesnard, Co-Director of the French National center for Thrombotic MicroAngiopathies (CNR-MAT), aimed at improving [...]
-
News Platform features
27 September 2021
SeqOne unlocks the power of Illumina’s TruSightTM Oncology 500
With the addition of the TSO500 pan-cancer NGS assay for genomic profiling of tumour samples, SeqOne now provides oncologists with the most comprehensive genomic data [...]
-
Platform features
3 December 2020
Detect fusion genes with SeqOne!
https://youtu.be/eYfj7JlKc4k RNAseq analysis is now possible using the SeqOne Platform so that you can include the detection of expressed SNVs, Indels and fusion genes in [...]
-
Platform features Science
14 May 2020
Mobile element insertion (MEI) detection for NGS based clinical diagnostics
A growing number of scientific articles describe the pathogenic role of MEI’s, bringing a renewed focus on their importance in clinical diagnosis. Although NGS makes [...]
-
Platform features Science
31 March 2020
Challenges and importance of mid-sized deletion identification for genomic medicine
The clinical importance of mid-sized deletions is becoming increasingly apparent with a growing number of variants of this type being identified as pathogenic in the [...]
